Good evening :)
Place Order
Add to Watchlist

Vanta Bioscience Ltd

VANTABIO

Vanta Bioscience Ltd

VANTABIO
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹30 cr, stock is ranked 3,883
High RiskStock is 4.21x as volatile as Nifty
45.625.00% (-2.40)
45.625.00% (-2.40)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹30 cr, stock is ranked 3,883
High RiskStock is 4.21x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹30 cr, stock is ranked 3,883
High RiskStock is 4.21x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
2.34
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.356.540.51%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

The company is a preclinical contract research company. It provides preclinical safety assessment services, assessment services for evaluating the safety of the active pharmaceutical ingredients (API), etc.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -4.92%, vs industry avg of 4.51%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.1% to 0.06%

Loading...

Financial YearFY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue4.0412.6514.2510.0710.116.979.83
Raw Materialssubtract2.960.000.000.000.000.000.00
Power & Fuel Costsubtract0.981.040.540.550.751.01
Employee Costsubtract2.903.932.512.673.463.79
Selling & Administrative Expensessubtract3.233.301.942.003.082.39
Operating & Other expensessubtract2.041.501.101.001.381.22
Depreciation/Amortizationsubtract0.570.711.191.251.322.674.50
Interest & Other Itemssubtract0.201.691.952.142.355.895.75
Taxes & Other Itemssubtract0.290.400.340.140.14-3.78-6.51
EPS0.051.111.580.710.13-10.27-3.68
DPS0.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CareLabs & Life Sciences Services

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Vanta Bioscience Ltd-13.062.34
Divi's Laboratories Ltd98.7211.640.50%
Syngene International Ltd70.688.470.14%
Aarti Pharmalabs Ltd27.523.400.46%

Price Comparison

Compare VANTABIO with any stock or ETF
Compare VANTABIO with any stock or ETF
VANTABIO
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

No institutional holdings trend are available

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding69.36%0.00%0.00%0.00%30.64%

Mar 2023

Sep 2023

Mar 2024

Sep 2024

Shareholding History

MarSepMarSepMarSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

VANTABIO has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Corporate
Vanta Bioscience postpones board meeting

Vanta Bioscience has postponed the meeting of the Board of Directors which was scheduled to be held on 17 July 2024. The meeting will now be held on 19 July 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live